603392 万泰生物
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额7,285355,0821,537,8234,132,5931,681,948
投资活动产生之现金流量净额(76,997)(1,503,359)(2,053,737)(3,513,902)(1,014,103)
筹资活动产生之现金流量净额11,184(612,743)(893,260)3,126,89652,785
汇率变动对现金及现金等价物的影响(4,670)4,3857,61926,262(8,746)
现金及现金等价物净增加/(减少)(63,199)(1,756,636)(1,401,554)3,771,849711,884
期初现金及现金等价物余额2,027,0063,783,6425,185,1961,413,347701,463
期末现金及现金等价物余额1,963,8072,027,0063,783,6425,185,1961,413,347